{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:41:12Z","timestamp":1786372872188,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.2215\/cjn.05030709","type":"journal-article","created":{"date-parts":[[2009,8,20]],"date-time":"2009-08-20T21:53:15Z","timestamp":1250805195000},"page":"1405-1408","source":"Crossref","is-referenced-by-count":2,"title":["Cinacalcet Hydrochloride in Chronic Kidney Disease\u2013Mineral Bone Disorder"],"prefix":"10.2215","volume":"4","author":[{"given":"Keitaro","family":"Yokoyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20230601","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"R2-3-20230601","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1681\/ASN.2004060512","article-title":"Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: A randomized, double-blind, multicenter study","volume":"16","author":"Lindberg","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R3-3-20230601","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1093\/ndt\/gfh966","article-title":"Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl","volume":"20","author":"Moe","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R4-3-20230601","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5414\/CNP68010","article-title":"Cinacalcet HCL (Sensipar\/Mimpara) is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidism","volume":"68","author":"Sterrett","year":"2007","journal-title":"Clin Nephrol"},{"key":"R5-3-20230601","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1523-1755.2005.67139.x","article-title":"Achieving NKF-K\/DOQI bone metabolism and disease treatment goals with cinacalcet HCl","volume":"67","author":"Moe","year":"2005","journal-title":"Kidney Int"},{"key":"R6-3-20230601","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2215\/CJN.00870805","article-title":"CONTROL Investigators: Cinacalcet hydrochloride (Sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium x phosphate","volume":"2","author":"Chertow","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R7-3-20230601","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/ndt\/gfl840","article-title":"Implementation of \u2032K\/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease' after the introduction of cinacalcet in a population of patients on chronic haemodialysis","volume":"6","author":"Arenas","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R8-3-20230601","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000101727","article-title":"Long-term outcomes of cinacalcet and paricalcitol titration protocol for treatment of secondary hyperparathyroidism","volume":"27","author":"Lazar","year":"2007","journal-title":"Am J Nephrol"},{"key":"R9-3-20230601","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1093\/ndt\/gfn026","article-title":"Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism","volume":"23","author":"Block","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R10-3-20230601","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.2215\/CJN.01040308","article-title":"Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: The ACHIEVE study results","volume":"3","author":"Fishbane","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R11-3-20230601","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2215\/CJN.03591006","article-title":"The OPTIMA study: Assessing a new cinacalcet (Sensipar\/Mimpara) treatment algorithm for secondary hyperparathyroidism","volume":"3","author":"Messa","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R12-3-20230601","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/ndt\/gfm534","article-title":"KRN1493 Study Group: Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients","volume":"23","author":"Fukagawa","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R13-3-20230601","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000156717","article-title":"KRN1493 Study Group: Long-term cinacalcet HCl treatment improved bone metabolism in Japanese hemodialysis patients with secondary hyperparathyroidism","volume":"29","author":"Shigematsu","year":"2009","journal-title":"Am J Nephrol"},{"key":"R15-3-20230601","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1523-1755.2005.00517.x","article-title":"First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl","volume":"68","author":"Martin","year":"2005","journal-title":"Kidney Int"},{"key":"R16-3-20230601","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/ndt\/gfn654","article-title":"Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism","volume":"24","author":"Meola","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R17-3-20230601","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/ndt\/gfm172","article-title":"Six cases of successful cinacalcet cessation in haemodialysis patients treated for secondary hyperparathyroidism","volume":"22","author":"Jean","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R18-3-20230601","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1097\/01.ASN.0000141016.20133.33","article-title":"Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency","volume":"15","author":"Mizobuchi","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R19-3-20230601","doi-asserted-by":"crossref","first-page":"F1390","DOI":"10.1152\/ajprenal.00262.2006","article-title":"The calcimimetic R-568 increases vitamin D receptor expression in rat parathyroid glands","volume":"292","author":"Rodriguez","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"R20-3-20230601","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2215\/CJN.05241008","article-title":"Cinacalcet use patterns and effect on laboratory values and other medications in a large dialysis organization, 2004 through 2006","volume":"4","author":"St Peter","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R21-3-20230601","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1523-1755.2005.00596.x","article-title":"Effects of the calcimimetic cinacalcet HCL on cardiovascular disease, fracture, and health related quality of life in secondary hyperparathyroidism","volume":"68","author":"Cunningham","year":"2005","journal-title":"Kidney Int"},{"key":"R22-3-20230601","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.1523-1755.1998.00782.x","article-title":"NPS R-568 halts or reverses osteitis fibrosa in uremic rats","volume":"53","author":"Wada","year":"1998","journal-title":"Kidney Int"},{"key":"R23-3-20230601","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5414\/CNP69269","article-title":"An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism","volume":"69","author":"Malluche","year":"2008","journal-title":"Clin Nephrol"},{"key":"R24-3-20230601","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/ki.2008.407","article-title":"Cinacalcet suppresses calcification of the aorta and heart in uremic rats","volume":"74","author":"Kawata","year":"2008","journal-title":"Kidney Int"},{"key":"R25-3-20230601","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5414\/CNP71207","article-title":"Cinacalcet reduces vascular and soft tissue calcification in secondary hyperparathyroidism (SHPT) in hemodialysis patients","volume":"71","author":"Aladren Regidor","year":"2009","journal-title":"Clin Nephrol"},{"key":"R26-3-20230601","doi-asserted-by":"crossref","first-page":"898","DOI":"10.2215\/CJN.04381206","article-title":"CONTROL Investigators: Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): Rationale and design overview","volume":"2","author":"Chertow","year":"2007","journal-title":"Clin J Am Nephrol"},{"key":"R27-3-20230601","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5414\/CNP57131","article-title":"Calcium-sensing receptor gene polymorphism affects the parathyroid response to moderate hypercalcemic suppression in patients with end-stage renal disease","volume":"57","author":"Yokoyama","year":"2002","journal-title":"Clin Nephrol"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-200909000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:38:56Z","timestamp":1786369136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-200909000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.05030709","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}